Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 150

1.

HLA associations with infliximab-induced liver injury.

Bruno CD, Fremd B, Church RJ, Daly AK, Aithal GP, Björnsson ES, Larrey D, Watkins PB, Chow CR.

Pharmacogenomics J. 2020 Feb 6. doi: 10.1038/s41397-020-0159-0. [Epub ahead of print]

PMID:
32024945
2.

Ashwagandha-induced liver injury: A case series from Iceland and the US Drug-Induced Liver Injury Network.

Björnsson HK, Björnsson ES, Avula B, Khan IA, Jonasson JG, Ghabril M, Hayashi PH, Navarro V.

Liver Int. 2020 Jan 28. doi: 10.1111/liv.14393. [Epub ahead of print]

PMID:
31991029
3.

Acute lower gastrointestinal bleeding: A population-based five-year follow-up study.

Hreinsson JP, Ægisdottir S, Bjornsson ES.

United European Gastroenterol J. 2019 Dec;7(10):1330-1336. doi: 10.1177/2050640619863517. Epub 2019 Jul 8.

4.

[Gastrointestinal bleeding in Iceland and in broader terms - a review].

Hreinsson JP, Bjornsson ES.

Laeknabladid. 2019 Dec;105(12):563-569. doi: 10.17992/lbl.2019.12.262. Icelandic.

5.

Epidemiology, Predisposing Factors, and Outcomes of Drug-Induced Liver Injury.

Björnsson ES.

Clin Liver Dis. 2020 Feb;24(1):1-10. doi: 10.1016/j.cld.2019.08.002. Epub 2019 Oct 28. Review.

PMID:
31753242
6.

Problems Associated with Deprescribing of Proton Pump Inhibitors.

Helgadottir H, Bjornsson ES.

Int J Mol Sci. 2019 Nov 2;20(21). pii: E5469. doi: 10.3390/ijms20215469. Review.

7.

Common and Rare Sequence Variants Influencing Tumor Biomarkers in Blood.

Olafsson S, Alexandersson KF, Gizurarson JGK, Hauksdottir K, Gunnarsson O, Olafsson K, Gudmundsson J, Stacey SN, Sveinbjornsson G, Saemundsdottir J, Bjornsson ES, Olafsson S, Bjornsson S, Orvar KB, Vikingsson A, Geirsson AJ, Arinbjarnarson S, Bjornsdottir G, Thorgeirsson TE, Sigurdsson S, Halldorsson GH, Magnusson OT, Masson G, Holm H, Jonsdottir I, Sigurdardottir O, Eyjolfsson GI, Olafsson I, Sulem P, Thorsteinsdottir U, Jonsson T, Rafnar T, Gudbjartsson DF, Stefansson K.

Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):225-235. doi: 10.1158/1055-9965.EPI-18-1060. Epub 2019 Oct 30.

PMID:
31666285
8.

Drug-Induced Liver Injury - Types and Phenotypes. Reply.

Hoofnagle JH, Björnsson ES.

N Engl J Med. 2019 Oct 3;381(14):1396. doi: 10.1056/NEJMc1911063. No abstract available.

PMID:
31577895
9.

[Primary sclerosing cholangitis in Iceland 1992-2012].

Gudnason HO, Kristinsson JO, Bergmann OM, Olafsson S, Jonasson JG, Bjornsson ES.

Laeknabladid. 2019 Sep;105(9):371-376. doi: 10.17992/lbl.2019.09.245. Icelandic.

10.

A significant proportion of patients with choledocholithiasis have markedly elevated alanine aminotransferase.

Björnsson HK, Björnsson ES.

Scand J Gastroenterol. 2019 Sep;54(9):1155-1159. doi: 10.1080/00365521.2019.1657177. Epub 2019 Sep 3.

PMID:
31479284
11.

RE: Incidence and Etiology of Drug-Induced Liver Injury in Mainland China.

Devarbhavi H, Bjornsson ES.

Gastroenterology. 2019 Nov;157(5):1437-1438. doi: 10.1053/j.gastro.2019.06.045. Epub 2019 Aug 20. No abstract available.

PMID:
31442436
12.

Drug-induced liver injury.

Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-Ublick GA, Watkins PB, Devarbhavi H, Merz M, Lucena MI, Kaplowitz N, Aithal GP.

Nat Rev Dis Primers. 2019 Aug 22;5(1):58. doi: 10.1038/s41572-019-0105-0. Review.

PMID:
31439850
13.

Increased incidence of autoimmune hepatitis is associated with wider use of biological drugs.

Valgeirsson KB, Hreinsson JP, Björnsson ES.

Liver Int. 2019 Dec;39(12):2341-2349. doi: 10.1111/liv.14224. Epub 2019 Aug 30.

PMID:
31436903
14.

Drug-Induced Liver Injury - Types and Phenotypes.

Hoofnagle JH, Björnsson ES.

N Engl J Med. 2019 Jul 18;381(3):264-273. doi: 10.1056/NEJMra1816149. Review. No abstract available.

PMID:
31314970
15.

Biochemical response to ursodeoxycholic acid among PBC patients: a nationwide population-based study.

Örnolfsson KT, Lund SH, Olafsson S, Bergmann OM, Björnsson ES.

Scand J Gastroenterol. 2019 May;54(5):609-616. doi: 10.1080/00365521.2019.1606931. Epub 2019 May 10.

PMID:
31074667
16.

Shared Genetic Risk Factors Across Carbamazepine-Induced Hypersensitivity Reactions.

Nicoletti P, Barrett S, McEvoy L, Daly AK, Aithal G, Lucena MI, Andrade RJ, Wadelius M, Hallberg P, Stephens C, Bjornsson ES, Friedmann P, Kainu K, Laitinen T, Marson A, Molokhia M, Phillips E, Pichler W, Romano A, Shear N, Sills G, Tanno LK, Swale A, Floratos A, Shen Y, Nelson MR, Watkins PB, Daly MJ, Morris AP, Alfirevic A, Pirmohamed M.

Clin Pharmacol Ther. 2019 Nov;106(5):1028-1036. doi: 10.1002/cpt.1493. Epub 2019 Jul 3.

PMID:
31066027
17.

Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy.

Helgadóttir H, Lund SH, Gizurarson S, Metz DC, Björnsson ES.

J Clin Gastroenterol. 2020 Mar;54(3):227-234. doi: 10.1097/MCG.0000000000001200.

PMID:
30994520
18.

Incidence of diverticular bleeding: a population-based study.

Olafsson GD, Hreinsson JP, Björnsson ES.

Scand J Gastroenterol. 2019 Feb;54(2):205-209. doi: 10.1080/00365521.2019.1566494. Epub 2019 Feb 10.

PMID:
30739520
19.

Risk factors for chronic and recurrent pancreatitis after first attack of acute pancreatitis.

Magnusdottir BA, Baldursdottir MB, Kalaitzakis E, Björnsson ES.

Scand J Gastroenterol. 2019 Jan;54(1):87-94. doi: 10.1080/00365521.2018.1550670. Epub 2019 Jan 31.

PMID:
30700163
20.

Long-Term Outcomes After Drug-Induced Liver Injury.

Hayashi PH, Bjornsson ES.

Curr Hepatol Rep. 2018 Sep;17(3):292-299. doi: 10.1007/s11901-018-0411-0. Epub 2018 Jul 2.

21.

A Missense Variant in PTPN22 is a Risk Factor for Drug-induced Liver Injury.

Cirulli ET, Nicoletti P, Abramson K, Andrade RJ, Bjornsson ES, Chalasani N, Fontana RJ, Hallberg P, Li YJ, Lucena MI, Long N, Molokhia M, Nelson MR, Odin JA, Pirmohamed M, Rafnar T, Serrano J, Stefánsson K, Stolz A, Daly AK, Aithal GP, Watkins PB; Drug-Induced Liver Injury Network (DILIN) investigators; International DILI consortium (iDILIC).

Gastroenterology. 2019 May;156(6):1707-1716.e2. doi: 10.1053/j.gastro.2019.01.034. Epub 2019 Jan 18.

PMID:
30664875
22.

Gastroenteropancreatic neuroendocrine tumors in Iceland: a population-based study.

Gudmundsdottir H, Möller PH, Jonasson JG, Björnsson ES.

Scand J Gastroenterol. 2019 Jan;54(1):69-75. doi: 10.1080/00365521.2018.1553061. Epub 2019 Jan 13.

PMID:
30638086
23.

Genome-wide association meta-analysis yields 20 loci associated with gallstone disease.

Ferkingstad E, Oddsson A, Gretarsdottir S, Benonisdottir S, Thorleifsson G, Deaton AM, Jonsson S, Stefansson OA, Norddahl GL, Zink F, Arnadottir GA, Gunnarsson B, Halldorsson GH, Helgadottir A, Jensson BO, Kristjansson RP, Sveinbjornsson G, Sverrisson DA, Masson G, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Holm H, Jonsdottir I, Olafsson S, Steingrimsdottir T, Rafnar T, Bjornsson ES, Thorsteinsdottir U, Gudbjartsson DF, Sulem P, Stefansson K.

Nat Commun. 2018 Nov 30;9(1):5101. doi: 10.1038/s41467-018-07460-y.

24.

The SHA2PE score: a new score for lower gastrointestinal bleeding that predicts low-risk of hospital-based intervention.

Hreinsson JP, Sigurdardottir R, Lund SH, Bjornsson ES.

Scand J Gastroenterol. 2018 Dec;53(12):1484-1489. doi: 10.1080/00365521.2018.1532019. Epub 2018 Nov 20.

PMID:
30457020
25.

Elevation in Cell Cycle and Protein Metabolism Gene Transcription in Inactive Colonic Tissue From Icelandic Patients With Ulcerative Colitis.

Vinayaga-Pavan M, Frampton M, Pontikos N, Levine AP, Smith PJ, Jonasson JG, Björnsson ES, Segal AW, Smith AM.

Inflamm Bowel Dis. 2019 Jan 10;25(2):317-327. doi: 10.1093/ibd/izy350.

26.

A rare missense variant in NR1H4 associates with lower cholesterol levels.

Deaton AM, Sulem P, Nioi P, Benonisdottir S, Ward LD, Davidsson OB, Lao S, Helgadottir A, Fan F, Jensson BO, Norddahl GL, Jonasdottir A, Jonasdottir A, Sigurdsson A, Kristjansson RP, Oddsson A, Arnadottir GA, Jonsson H, Olafsson I, Eyjolfsson GI, Sigurdardottir O, Bjornsson ES, Olafsson S, Steingrimsdottir T, Rafnar T, Thorgeirsson G, Masson G, Thorleifsson G, Gudbjartsson DF, Holm H, Thorsteinsdottir U, Stefansson K.

Commun Biol. 2018 Feb 8;1:14. doi: 10.1038/s42003-018-0015-9. eCollection 2018.

27.

Sclerosing Cholangitis-Like Changes on Magnetic Resonance Cholangiography in Patients With Drug Induced Liver Injury.

Ahmad J, Rossi S, Rodgers SK, Ghabril M, Fontana RJ, Stolz A, Hayashi PH, Barnhart H, Kleiner DE, Bjornsson ES.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):789-790. doi: 10.1016/j.cgh.2018.06.035. Epub 2018 Jun 30.

PMID:
29966706
28.

Proton-pump inhibitors among adults: a nationwide drug-utilization study.

Hálfdánarson ÓÖ, Pottegård A, Björnsson ES, Lund SH, Ogmundsdottir MH, Steingrímsson E, Ogmundsdottir HM, Zoega H.

Therap Adv Gastroenterol. 2018 May 30;11:1756284818777943. doi: 10.1177/1756284818777943. eCollection 2018.

29.

Lifetime alcohol intake and pattern of alcohol consumption in patients with alcohol-induced pancreatitis in comparison with patients with alcohol use disorder.

Juliusson SJ, Nielsen JK, Runarsdottir V, Hansdottir I, Sigurdardottir R, Björnsson ES.

Scand J Gastroenterol. 2018 Jun;53(6):748-754. doi: 10.1080/00365521.2018.1455893. Epub 2018 Mar 29.

PMID:
29595342
30.

Treatment as Prevention for Hepatitis C (TraP Hep C) - a nationwide elimination programme in Iceland using direct-acting antiviral agents.

Olafsson S, Tyrfingsson T, Runarsdottir V, Bergmann OM, Hansdottir I, Björnsson ES, Johannsson B, Sigurdardottir B, Fridriksdottir RH, Löve A, Hellard M, Löve TJ, Gudnason T, Heimisdottir M, Gottfredsson M.

J Intern Med. 2018 May;283(5):500-507. doi: 10.1111/joim.12740. Epub 2018 Mar 7.

PMID:
29512219
31.

[Hepatitis A in Iceland].

Kristinsdóttir H, Löve A, Bjornsson ES.

Laeknabladid. 2018 Mars;104(3):127-131. doi: 10.17992/lbl.2018.03.176. Icelandic.

32.

Drug-induced cholestasis.

Sundaram V, Björnsson ES.

Hepatol Commun. 2017 Sep 11;1(8):726-735. doi: 10.1002/hep4.1088. eCollection 2017 Oct. Review.

33.

Mortality associated with drug-induced liver injury (DILI).

Björnsson ES, Björnsson HK.

Transl Gastroenterol Hepatol. 2017 Dec 19;2:114. doi: 10.21037/tgh.2017.11.16. eCollection 2017. No abstract available.

34.

Low prevalence of hepatitis E in Iceland: a seroepidemiological study.

Löve A, Björnsdottir TB, Olafsson S, Björnsson ES.

Scand J Gastroenterol. 2018 Mar;53(3):293-296. doi: 10.1080/00365521.2017.1420218. Epub 2018 Jan 8.

PMID:
29310474
35.

Fourteen sequence variants that associate with multiple sclerosis discovered by meta-analysis informed by genetic correlations.

Olafsson S, Stridh P, Bos SD, Ingason A, Euesden J, Sulem P, Thorleifsson G, Gustafsson O, Johannesson A, Geirsson AJ, Thorsson AV, Sigurgeirsson B, Ludviksson BR, Olafsson E, Kristjansdottir H, Jonasson JG, Olafsson JH, Orvar KB, Benediktsson R, Bjarnason R, Kristjansdottir S, Gislason T, Valdimarsson T, Mikaelsdottir E, Sigurdsson S, Jonsson S, Rafnar T, Aarsland D, Djurovic S, Fladby T, Knudsen GP, Celius EG, Myhr KM, Grondal G, Steinsson K, Valdimarsson H, Bjornsson S, Bjornsdottir US, Bjornsson ES, Nilsson B, Andreassen OA, Alfredsson L, Hillert J, Kockum IS, Masson G, Thorsteinsdottir U, Gudbjartsson DF, Stefansson H, Hjaltason H, Harbo HF, Olsson T, Jonsdottir I, Stefansson K.

NPJ Genom Med. 2017 Aug 8;2:24. doi: 10.1038/s41525-017-0027-2. eCollection 2017.

36.

Using the Icelandic genealogical database to define the familial risk of primary biliary cholangitis.

Örnolfsson KT, Olafsson S, Bergmann OM, Gershwin ME, Björnsson ES.

Hepatology. 2018 Jul;68(1):166-171. doi: 10.1002/hep.29675. Epub 2018 May 6.

PMID:
29159924
37.

Incidence, diagnostic, treatment and outcome of patients diagnosed with cancer of the pancreas during 1986-2009: a population-based study.

Jonsdottir SB, Juliusson G, Kristinsson JÖ, Hreinsson JP, Jonasson JG, Björnsson ES.

Scand J Gastroenterol. 2018 Jan;53(1):100-106. doi: 10.1080/00365521.2017.1390598. Epub 2017 Oct 23.

PMID:
29058490
38.

Physical activity may decrease the likelihood of children developing constipation.

Seidenfaden S, Ormarsson OT, Lund SH, Bjornsson ES.

Acta Paediatr. 2018 Jan;107(1):151-155. doi: 10.1111/apa.14067. Epub 2017 Sep 27.

PMID:
28898506
39.

Secondary sclerosing cholangitis in critically ill patients: current perspectives.

Gudnason HO, Björnsson ES.

Clin Exp Gastroenterol. 2017 Jun 23;10:105-111. doi: 10.2147/CEG.S115518. eCollection 2017. Review.

40.

Drug-Induced Autoimmune Hepatitis: Response to Corticosteroids and Lack of Relapse After Cessation of Steroids.

Björnsson ES, Bergmann O, Jonasson JG, Grondal G, Gudbjornsson B, Olafsson S.

Clin Gastroenterol Hepatol. 2017 Oct;15(10):1635-1636. doi: 10.1016/j.cgh.2017.05.027. Epub 2017 May 20. No abstract available.

PMID:
28535988
41.

Predictors of the Clinical Course of Primary Sclerosing Cholangitis.

Kalaitzakis E, Björnsson ES.

Gastroenterology. 2017 Jun;152(8):1829-1830. doi: 10.1053/j.gastro.2017.04.026. Epub 2017 Apr 28. No abstract available.

PMID:
28461191
42.

Hepatitis due to Epstein-Barr virus and cytomegalovirus: clinical features and outcomes.

Leonardsson H, Hreinsson JP, Löve A, Björnsson ES.

Scand J Gastroenterol. 2017 Aug;52(8):893-897. doi: 10.1080/00365521.2017.1319972. Epub 2017 Apr 27.

PMID:
28446048
43.

Antibiotic susceptibility of Helicobacter pylori in Iceland.

Gunnarsdottir AI, Gudjonsson H, Hardardottir H, Jonsdottir KD, Bjornsson ES.

Infect Dis (Lond). 2017 Sep;49(9):647-654. doi: 10.1080/23744235.2017.1317359. Epub 2017 Apr 25.

PMID:
28440099
44.

Helicobacter pylori infection in Icelandic children.

Asgeirsdottir GA, Kjartansdottir I, Olafsdottir AS, Hreinsson JP, Hrafnkelsson H, Johannsson E, Björnsson ES.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):686-690. doi: 10.1080/00365521.2017.1304986. Epub 2017 Mar 30.

PMID:
28355955
45.

Drug-induced liver injury due to antibiotics.

Björnsson ES.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):617-623. doi: 10.1080/00365521.2017.1291719. Epub 2017 Feb 20. Review.

PMID:
28276834
46.

The incidence and outcome of ischemic colitis in a population-based setting.

Yngvadottir Y, Karlsdottir BR, Hreinsson JP, Ragnarsson G, Mitev RUM, Jonasson JG, Möller PH, Björnsson ES.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):704-710. doi: 10.1080/00365521.2017.1291718. Epub 2017 Feb 23.

PMID:
28276832
47.

Chronic cholestatic liver diseases.

Waldum HL, Björnsson ES, Brenna E.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):788. doi: 10.1080/00365521.2017.1296276. Epub 2017 Feb 28. No abstract available.

PMID:
28276829
48.

Lifetime drinking history in patients with alcoholic liver disease and patients with alcohol use disorder without liver disease.

Nielsen JK, Olafsson S, Bergmann OM, Runarsdottir V, Hansdottir I, Sigurdardottir R, Björnsson ES.

Scand J Gastroenterol. 2017 Jun - Jul;52(6-7):762-767. doi: 10.1080/00365521.2017.1295466. Epub 2017 Feb 28.

PMID:
28276826
49.

Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.

Oskarsdóttir AR, Gudmundsdottir BR, Indridason OS, Lund SH, Arnar DO, Bjornsson ES, Magnusson MK, Jensdottir HM, Vidarsson B, Francis CW, Onundarson PT.

J Thromb Thrombolysis. 2017 May;43(4):550-561. doi: 10.1007/s11239-017-1482-4.

PMID:
28214948
50.

Idiosyncratic drug-induced liver injury associated with bile duct loss and vanishing bile duct syndrome: Rare but has severe consequences.

Björnsson ES, Jonasson JG.

Hepatology. 2017 Apr;65(4):1091-1093. doi: 10.1002/hep.29040. Epub 2017 Mar 3. No abstract available.

PMID:
28073177

Supplemental Content

Loading ...
Support Center